BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4058395)

  • 1. [General grouping of osteoporosis therapy].
    Camanni F
    Minerva Endocrinol; 1985; 10(1):57-60. PubMed ID: 4058395
    [No Abstract]   [Full Text] [Related]  

  • 2. Involutional osteoporosis.
    Riggs BL; Melton LJ
    N Engl J Med; 1986 Jun; 314(26):1676-86. PubMed ID: 3520321
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 1980 May; 22(11):45-6. PubMed ID: 7374621
    [No Abstract]   [Full Text] [Related]  

  • 4. The pharmacology of bone.
    Raisz LG
    Ration Drug Ther; 1971 Jun; 5(6):1-7. PubMed ID: 5565260
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathogenesis and therapy of osteoporosis in the postmenopausal period].
    Keck E; Krüskemper HL
    Gynakologe; 1986 Dec; 19(4):220-6. PubMed ID: 3817593
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventing osteoporosis: current practices and problems.
    Pogrund H; Bloom RA; Menczel J
    Geriatrics; 1986 May; 41(5):55-61, 64-8, 71. PubMed ID: 3957044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of osteoporosis (with the exception of hormone replacement and its derivates].
    Lamy O; Mischler C; Krieg MA
    Rev Med Suisse Romande; 2002 Aug; 122(8):389-93. PubMed ID: 12357732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic regimens: implications and efficacy for treating osteoporosis.
    Bauwens SF
    AAOHN J; 1987 Dec; 35(12):550-4. PubMed ID: 3689505
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of thyrocalcitonin in osteogenesis].
    Briskin AI
    Ortop Travmatol Protez; 1973 Dec; 34(12):69-71. PubMed ID: 4790654
    [No Abstract]   [Full Text] [Related]  

  • 10. New concepts in the treatment of osteoporosis.
    Jowsey J; Riggs BL; Kelly PJ
    Postgrad Med; 1972 Oct; 52(4):62-7. PubMed ID: 5070959
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence-based medicine and osteoporosis: a comparison of fracture risk reduction data from osteoporosis randomised clinical trials.
    Meunier PJ
    Int J Clin Pract; 1999 Mar; 53(2):122-9. PubMed ID: 10344048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human parathyroid hormone (1-34) as a new therapeutic agent for osteoporosis].
    Isogai Y
    Clin Calcium; 2005 Jan; 15(1):18-24. PubMed ID: 15632468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of osteoporosis with calcium infusions.
    Pak CY; Bartter FC
    Semin Drug Treat; 1972; 2(1):39-46. PubMed ID: 5048563
    [No Abstract]   [Full Text] [Related]  

  • 14. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolic bone diseases: various factors influencing bone resorption and osteogenesis--with special reference to the mechanism of action--steroid hormone].
    Morimoto Y
    Nihon Rinsho; 1986 Nov; 44(11):2391-8. PubMed ID: 3546790
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of osteoporosis. Antiresorptive therapy.
    Miller PD
    Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,25(OH)2 vitamin D3 in osteoporosis--a pilot study.
    Haas HG; Dambacher MA; Guncaga J; Lauffenburger T; Lämmle B; Olah J
    Horm Metab Res; 1979 Feb; 11(2):168-71. PubMed ID: 437680
    [No Abstract]   [Full Text] [Related]  

  • 18. The microradiographic assessment of bone structure.
    Jowsey J
    Triangle; 1973; 12(3):93-101. PubMed ID: 4766415
    [No Abstract]   [Full Text] [Related]  

  • 19. Current views on osteoporosis.
    Young MM
    J Ir Med Assoc; 1973 Sep; 66(17):477-80. PubMed ID: 4593980
    [No Abstract]   [Full Text] [Related]  

  • 20. Past and future of anabolic agents.
    Ringe JD
    Ann Med Interne (Paris); 2000 Oct; 151(6):482-9. PubMed ID: 11104928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.